Fasteris to Provide Agilent's SureSelect in Europe | GenomeWeb

NEW YORK (GenomeWeb News) – Agilent Technologies said today that Swiss genomics services company Fasteris will provide Agilent's target enrichment services for next-generation sequencing.

Fasteris was named the first European Certified-Service Provider for Agilent's SureSelect Target Enrichment System, Agilent said.

Fasteris demonstrated proficiency using the SureSelect system with Illumina's Genome Analyzer. Agilent and Illumina have a non-exclusive co-marketing agreement that supports the Agilent system as optimized for the Genome Analyzer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: variant linked to obesity risk in Samoans, health of cloned animals, and more.

Researchers explore using genome editing to treat inherited eye diseases, New Scientist reports.

Olympic athletes this summer will also undergo gene doping testing, according to Wired.

A study finds that the lower funding rate seen among women of color is more due to race than gender, according to BuzzFeed News.